Angola & Moderna

Angola: Angola is considered at high risk for an Ebola outbreak due to known travel routes and porous border crossings.

Moderna: Moderna is utilizing its mRNA technology to develop a vaccine for the Bundibugyo strain of Ebola, with funding from CEPI, aiming to rapidly train the body to fight the virus.

Angola: Angola is considered at high risk for its own Ebola outbreaks due to known travel routes and porous border crossings with the Democratic Republic of the Congo.

Moderna: Moderna is a key partner in the urgent high-level coordination meeting convened by United States — Centers for Disease Control and Prevention, potentially involved in assessing medical countermeasures for the Ebola outbreak.

Angola: Angola>>> is one of ten African countries identified by the United States — Centers for Disease Control and Prevention>>> as being at elevated risk of Ebola transmission due to cross-border population movement.

Moderna: Moderna is one of the entities developing an experimental vaccine for the Bundibugyo virus, which could lead to future revenue and enhance its reputation in vaccine development.